šQualifications
PhD in Pharmaceutical Science with a focus on Pharmaceutical Chemistry (2014) MSc in Pharmaceutical Science with a specialization in Pharmaceutical Chemistry (2009) BSc in Pharmaceutical Science from Al-Azhar University (2002)
š¼Work Experience
Associate Professor of Pharmaceutical Chemistry (2019 – Present) Ā Main Responsibilities: Teaching courses: Pharmaceutical Chemistry I, Pharmaceutical Chemistry II Supervision of postgraduate students Lecturer of Pharmaceutical Chemistry (2014 – 2019) Ā Main Responsibilities: Teaching courses: Pharmaceutical Chemistry I, Pharmaceutical Chemistry II Supervision of practical courses Supervision of postgraduate students Assistant Lecturer of Pharmaceutical Chemistry (2012 – 2014) Ā Main Responsibilities: Supervision and teaching of practical courses Participation in practical exams Preparing to obtain the PhD degree National Research Center, Pharmaceutical and Drug Industries Division, Therapeutic Chemistry Department: Pharmacist (2003-2006) Researcher Assistant (2006-2009) Assistant Researcher (2009-2012)
šEducation History
Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry, Al-Azhar University (Girls)- Cairo, Egypt (2014) Master in Pharmaceutical Sciences (Pharmaceutical Chemistry), Al-Azhar University (Girls)- Cairo, Egypt (2009) Bachelor of Pharmacy, Al-Azhar University – Cairo, Egypt (2002)
Other Activities
Proficient in Chemoffice 2016, Scifinder, and Molsoft ICM 3.4-8C program. Ā Completed a Training Course of “Occupational Safety and Health” at Training and Skills Development Center, National Research Centre (Egypt, January 17-21, 2004). Ā Completed a Training Course of “Scientific Writing” at Training and Skills Development Center, National Research Centre (Egypt, May 24-June 2, 2004). Ā Passed the International Computer Driving Licence Exam (ICDL) in 2010. Ā Participation in organizing the 3rd International Conference of Pharmaceutical and Drug Industries Division, National Research Centre under the theme of Research and Development in Drugs (Future Trends) (March 6-8, 2007). Ā Participation as a speaker in the 4th International Conference of Pharmaceutical and Drug Industries Division, National Research Centre under the theme of Research and Development in Drugs (Current Challenges) (March 3-5, 2009). Ā Completed a Training Course of “Computer-aided Drug Design Using MOE Software” at Medicinal Chemistry Department, Faculty of Pharmacy, Assiut University (Egypt, January 26-28, 2013). Ā Participation as a poster presenter in the 5th International Chemistry Conference under the theme “Chemistry for Durable Globe and Society Welfare,” Abha, Saudi Arabia (April 26-29, 2014). Ā Completed a Training Course of “Structure-Based, Ligand-Based Drug Design Using Discovery Studio Software” at Professional Development Program, Faculty of Pharmacy, Misr International University (Egypt, September 2014).
šAwards
The Best Poster Award at the 4th International Conference on New Horizons in Basic and Applied Sciences (ICNHBAS2019), Faculty of Science, Al-Azhar University, Assuit, Egypt (July 26-29, 2019).Ā The Best Poster Award at the 15th International Conference on Chemistry and its Role in Development (ICCRD ’15), Faculty of Science, Mansoura University, Hurghada, Egypt (August 9-13, 2021).Ā The Best Scientific Production Award at the Faculty of Pharmacy (Girls), Al-Azhar University (2021-2022).
Membership in Scientific Societies
Member of The Egyptian Chemical Society. Member of the Arab Association of Pharmacy Progress. Member of The National Committee of Drugs by the Academy of Scientific Research and Technology (ASRT) for the term 2022-2025. Member of The Organization for Women in Science for the Developing World (OWSD), Trieste, Italy.
Reviewer in Scientific Journals
Reviewer for the Journal of Enzyme Inhibition and Medicinal Chemistry. Reviewer for Springer Nature Applied Sciences. Ā Reviewer for Breast Cancer: Targets and Therapy. Reviewer for Synthetic Communications. Reviewer for the Journal of Molecular Structure Reviewer for the Egyptian Journal of Chemistry. Reviewer for the Egyptian Pharmaceutical Journal. Reviewer for Molecules. Reviewer for Future Medicinal Chemistry.
š§ŖResearch Projects Involvement
Member in project No. 7020103: “Anti-inflammatory agents: new derivatives as cyclooxygenase inhibitors” Funded by NRC, Cairo, Egypt (2004-2007). Member in project No. 9100102: “Oriented synthesis & pharmacological evaluation of novel organic compounds as anticancer agents” Funded by NRC, Cairo, Egypt (2010-2013). Ā Member in project No. P100208: “Synthesis, molecular modeling studies and biological evaluation of novel pyrazole derivatives as antitumor and EGFR inhibitor” Funded by NRC, Cairo, Egypt (2015-2016). Ā Member in project No. P100205: “Oriented synthesis and anticancer evaluation of new organic compounds” Funded by NRC, Cairo, Egypt (2015-2016). Ā Member in project No. 11010312: “Oriented Synthesis and Molecular Modeling Studies of Novel Heterocyclic Derivatives Including Quinazoline, Pyrazole, benzimidazole and/or Pyrimidine Moieties of Expected Anti-Neoplastic Activity” Funded by NRC, Cairo, Egypt (2016-2019). Ā Member in project No. 11010315: “Synthesis and Molecular Modeling of Some Thiopyrimidine-5-carbonitrile Derivatives as Anticancer and Antimicrobial Agents” Funded by NRC, Cairo, Egypt (2016-2019). Ā Member in project No. 12060111: “Oriented synthesis and molecular modeling studies of novel derivatives including different heterocyclic moieties of expected anti-inflammatory, antihypertension, and anticancer activities” Funded by NRC, Cairo, Egypt (2019-2022). Ā Member in project No. 10191-cos-2020-1-3-I: “Design, Synthesis, Anticancer Activity and Molecular Modeling of New Hybrids Containing Triazole and Derived Glycosides” Funded by Qassim University, Qassim, Saudi Arabia (2020-2022). Ā Member in project No. 43327: “Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers” Funded by Science and Technology Development Fund (STDF), Cairo, Egypt (2020-2021). Ā Member in project No. IFPIP: 210-247-1442: “Design, Synthesis, Anticancer Evaluation and Molecular Docking of Novel Thiophene-based derivatives” Funded by King Abdulaziz University, Jeddah, Saudi Arabia (2021-2022). Ā Member in project No. IFPIP: 1237-247-1443: “Synthesis, bioevaluation, and in silico studies of novel pyridine and pyrazole derivatives as selective c-Met kinase inhibitors of potential anticancer activity” Funded by King Abdulaziz University, Jeddah, Saudi Arabia (2022-2023).